Decline in Glycolytic ATP Production Proposed as a Fundamental Mechanism Limiting Lifespan

Glycolytic ATP production declines with age, contributing to common aging phenotypes such as reduced cell division and impaired DNA & mitochondria repair.”

Aging has long been attributed to a range of biological processes, including DNA damage, telomere shortening, and mitochondrial dysfunction. Yet, these frameworks often describe downstream consequences rather than a single unifying cause. Despite decades of research, a central question remains unresolved: what ultimately determines lifespan across species? Increasing attention has turned to cellular energy metabolism—particularly pathways responsible for rapid ATP generation—as a potential key driver. Understanding how these metabolic changes unfold over time, and how they influence survival, regeneration, and disease, remains a major challenge in aging biology.

A new research perspective published in Volume 18 of Aging-US introduces a unifying concept in aging biology, titled “A decline in glycolytic ATP production is the fundamental mechanism limiting lifespan; species with an optimal rate of decline over time survived.”

The study was led by first and corresponding author Akihiko Taguchi and co-author Yuka Okinaka, both from the Department of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan, in collaboration with Carsten Claussen and Sheraz Gul from the Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany.

A New Concept in Aging Biology

Rather than viewing aging as the result of accumulated damage alone, the authors propose that a gradual decline in glycolytic ATP production represents a central mechanism underlying aging across species. Glycolysis plays a critical role in supporting rapid energy demands, cell division, DNA repair, and mitochondrial maintenance. A reduction in this pathway over time may therefore contribute directly to many of the functional declines observed with aging.

An Evolutionary Perspective on Lifespan

The authors put forward a simple but compelling hypothesis: species that evolved with an optimal rate of decline in glycolytic ATP production were more likely to survive through natural selection.

In environments with limited food resources, increased energy efficiency—achieved through a shift toward oxidative metabolism—may provide a survival advantage. While this adaptation may benefit the species as a whole, it may also come at the cost of reduced cellular repair capacity and regenerative potential over time.

Linking Metabolism to Aging Phenotypes

Glycolytic ATP production is approximately 100 times faster than oxidative phosphorylation and is essential for high-demand cellular processes. Its decline with age is associated with impaired tissue repair, reduced cellular turnover, and increased vulnerability to stress. In contrast, cells that maintain high glycolytic activity—such as cancer cells—exhibit sustained proliferation and extended survival, highlighting the central role of metabolism in determining cellular lifespan.

Explaining Differences in Lifespan Across Species

Taken together, this framework may help explain several longstanding observations, including the wide variation in lifespan among species, the absence of biological immortality in most organisms, and the exceptional longevity of certain species such as the naked mole rat. According to the authors, differences in the rate of glycolytic decline may underlie these biological distinctions.

Implications for Aging and Disease

The authors also point to links between reduced glycolytic activity and age-related conditions, including neurodegenerative diseases, chronic kidney disease, and sarcopenia. Evidence from experimental and clinical studies suggests that enhancing glycolysis may help preserve cellular function and slow disease progression, supporting the relevance of this metabolic framework.

Future Directions

While the study is largely conceptual, it opens new directions for research into aging and longevity. Targeting glycolytic pathways—through metabolic, genetic, or cell-based approaches—may represent a promising strategy for promoting healthy aging. Further studies will be required to determine how these insights can be translated into safe and effective therapeutic interventions.

Conclusion

This study proposes a shift in how aging is understood, positioning the decline in glycolytic ATP production as a fundamental determinant of lifespan shaped by evolutionary pressures. By integrating metabolism, evolution, and cellular biology, the authors provide a cohesive framework that may guide future research and therapeutic development in aging science.

Click here to read the full research perspective published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

Mitochondrial Circular RNAs: New Players in Human Aging

During mammalian aging, there are changes in abundance of noncoding RNAs including microRNAs, long noncoding RNAs, and circular RNAs.”

The aging of an organism is reflected not only in the function of its organs but also in the molecular signatures written into its cells. For years, scientists have cataloged the changes in protein-coding genes and various non-coding RNAs that occur as we grow older. However, one class of molecules—circular RNAs originating from the genome of our cellular power plants, the mitochondria—has remained largely unexplored.

A new research paper, titled “Aging-associated mitochondrial circular RNAs” published in Volume 18 of Aging-US by a multi-institutional team of researchers, provides the first detailed profile of these molecules and reveals a surprising link to cellular energy metabolism. 

The team’s investigation demonstrates that a specific mitochondrial circular RNA, circMT-RNR2, is depleted in older individuals and plays a direct role in regulating the TCA cycle, the engine of cellular energy production.

The Discovery: A Mitochondrial Circular RNA Lost with Age

The researchers began by analyzing circular RNA junctions in peripheral blood mononuclear cells (PBMCs) from 11 young adults (average age 30) and 11 older adults (average age 64). Using RNA sequencing data, they identified hundreds of circular RNA species.

The most striking finding was the source of these molecules. In young individuals, the vast majority of circular RNA junctions originated from the mitochondrial chromosome (chrM). Specifically, the most abundant circular RNAs were derived from a mitochondrial ribosomal RNA gene called MT-RNR2. In older individuals, however, these same circular RNA junctions were sharply depleted—a loss of nearly 90%.

This age-associated decline was not just a statistical observation. When the team examined human fibroblasts (skin cells) as they aged in culture, they saw the same pattern: levels of circMT-RNR2 dropped progressively as the cells approached senescence, the point at which they permanently stop dividing.

The Regulator: An RNA-Binding Protein Called GRSF1

If circMT-RNR2 disappears with age, what controls its production? The team turned their attention to GRSF1, a protein known to localize to mitochondrial RNA granules—specialized compartments where mitochondrial RNAs are processed.

Using a split-GFP system, they confirmed that GRSF1 resides within mitochondria. They then performed a PAR-CLIP analysis, a technique that identifies precisely which RNAs a protein binds to. The results showed that GRSF1 binds directly to several mitochondrial transcripts, including both the linear and circular forms of MT-RNR2. A specific RNA motif—UGxxGGUU—was identified as the recognition sequence for GRSF1 on its target RNAs.

When the researchers depleted GRSF1 from human fibroblasts, circMT-RNR2 levels plummeted. This established GRSF1 as a critical factor for maintaining the abundance of this mitochondrial circular RNA.

The Function: Scaffolding the TCA Cycle

The discovery that a circular RNA is lost with age raised an obvious question: what does it actually do? Given that MT-RNR2 originates from the mitochondria, the team hypothesized it might be involved in mitochondrial metabolism.

They performed RNA immunoprecipitation assays to see if circMT-RNR2 interacts with metabolic enzymes. The results revealed that both linear and circular MT-RNR2 bind to two key enzymes of the TCA cycle: SUCLG1 (part of succinyl-CoA synthetase) and SDHA (a component of succinate dehydrogenase complex II).

This binding appears to have functional consequences. When the team depleted MT-RNR2 from cells, levels of the TCA cycle metabolites fumarate and alpha-ketoglutarate declined. Conversely, reintroducing circMT-RNR2 restored fumarate levels. The circular RNA seemed to be acting as a scaffold, helping to assemble or stabilize the enzyme complexes that drive the TCA cycle.

The Consequence: Suppressing Cellular Senescence

If circMT-RNR2 supports energy production, its loss should accelerate aging at the cellular level. To test this, the team measured markers of cellular senescence—p16 and p21—after manipulating GRSF1 and circMT-RNR2.

Depleting GRSF1, which reduced circMT-RNR2, caused a sharp increase in p16 and p21 mRNA levels. However, when they reintroduced circMT-RNR2 into these GRSF1-depleted cells, the senescence markers returned to normal. The circular RNA alone was sufficient to reverse the senescence phenotype.

Further analysis showed that GRSF1 depletion broadly suppressed mitochondrial transcripts, and reintroducing circMT-RNR2 partially rescued this defect. The model that emerges is one where GRSF1 promotes the production of circMT-RNR2, which then scaffolds TCA cycle enzymes to maintain efficient energy production and keep cells in a proliferating, non-senescent state.

Implications for Future Research

This study opens several new avenues for investigation. First, it establishes that mitochondria produce circular RNAs with distinct functions, expanding our understanding of mitochondrial biology. Second, it identifies GRSF1 as a key regulator of these molecules, linking RNA-binding proteins to mitochondrial metabolism.

The finding that a single circular RNA can influence the entire TCA cycle suggests that non-coding RNAs may play broader roles in metabolism than previously appreciated. The authors propose that circMT-RNR2 may act similarly to other scaffold non-coding RNAs, like NEAT1, which assemble metabolic enzymes to accelerate biochemical reactions.

The mechanism by which MT-RNR2 produces a circular RNA remains intriguing. Since the gene lacks introns, conventional back-splicing cannot explain its circularization. The authors speculate that trans-splicing—a process more common in plants and trypanosomes—may be at work, potentially mediated by GRSF1 within mitochondrial RNA granules.

Future Perspectives and Conclusion

This research does not claim to have fully mapped the landscape of mitochondrial circular RNAs or their functions. Rather, it offers a compelling proof-of-concept that these molecules exist, change with age, and have measurable biological effects.

By integrating transcriptomic profiling, biochemical analysis, and functional studies, the team demonstrates that circMT-RNR2 is depleted during human aging and senescence, that it is regulated by GRSF1, and that it supports the TCA cycle by scaffolding metabolic enzymes.

The perspective that emerges is one where the mitochondria are not just passive energy generators but active participants in the aging process through their non-coding RNA output. Continued research will be needed to determine whether other mitochondrial circular RNAs have similar functions, how precisely they are generated, and whether they might serve as therapeutic targets to preserve metabolic health in older age.

Click here to read the full research paper published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

Fighting Premature Aging: How NAD+ Could Help Treat Werner Syndrome

“Werner syndrome (WS), caused by mutations in the RecQ helicase WERNER (WRN) gene, is a classical accelerated aging disease with patients suffering from several metabolic dysfunctions without a cure.”

Werner syndrome is a rare condition marked by accelerated aging. A recent study, featured as the cover paper in Aging (Aging-US), Volume 17, Issue 4, led by researchers at the University of Oslo and international collaborators, suggests that nicotinamide adenine dinucleotide (NAD+), a vital molecule involved in cellular energy production, may be key to understanding this disease and developing future strategies to manage it.

Understanding Werner Syndrome

Werner syndrome (WS) is a rare genetic condition that causes people to age more quickly than normal. By their 20s or 30s, individuals with WS often show signs typically associated with older age, such as cataracts, hair loss, thinning skin, and heart disease. This premature aging is caused by mutations in the WRN gene, which normally helps repair DNA and protect cells from damage. While the WRN gene’s role in maintaining genetic stability is well understood, the reasons behind the rapid decline of cells in WS patients are still not fully clear.

The Study: Investigating NAD+ in Werner Syndrome

Nicotinamide adenine dinucleotide levels naturally decline with age. In the study titled Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional proliferation,” researchers investigated whether this decline is more severe in people with WS and whether restoring NAD+ levels could help slow the aging process in these patients.

The research team, led by first author Sofie Lautrup and corresponding author Evandro F. Fang, used human stem and skin cells from WS patients, as well as gene-edited cells that mimic WS by lacking the WRN gene. These were always compared to control cells isolated from healthy individuals.

The researchers tracked how WRN deficiency affected NAD+ levels in mitochondria, the parts of the cell that generate energy. They then tested whether boosting NAD+ using a compound called nicotinamide riboside (NR)—a form of vitamin B3—could help restore normal cellular function. The team also used other strategies to raise mitochondrial NAD+ directly, including overexpressing a transporter protein known as SLC25A51. Their goal was to determine whether these approaches could reverse aging-related damage and restore cell growth affected by WRN mutations.

The Results: NAD+ Can Reduce Aging Signs

The findings confirmed that WRN-deficient cells had lower levels of mitochondrial NAD+ and showed signs of cellular aging, such as increased senescence and reduced proliferation. Treating these cells with NR significantly reduced aging markers and restored some normal functions in both stem and skin cells from WS patients. In healthy control cells, NR had no such effect, suggesting it works specifically in the context of NAD+ deficiency.

However, increasing NAD+ either through NR supplementation or by enhancing mitochondrial transport was not enough to fully restore cell division in lab-grown cells lacking WRN. This result suggests that while NAD+ supplementation is beneficial, the WRN gene itself plays a unique and irreplaceable role in supporting healthy cell growth.

The Breakthrough: Linking Mitochondrial NAD+ to Cell Aging

This study reveals a deeper role for the WRN gene beyond DNA repair. It shows that WRN also helps regulate how NAD+ is produced and used within cells, particularly in mitochondria. Without WRN, this system becomes unbalanced, accelerating cell aging. While boosting NAD+ helped reduce aging features in WS cells, the findings make clear that NAD+ therapy alone cannot replace the broader functions of WRN.

The Impact: A Step Toward Slowing Down Cellular Aging

This is the first study to directly show how low mitochondrial NAD+ contributes to premature aging in WS. Beyond its relevance to WS, the research highlights the broader potential of targeting NAD+ metabolism as a strategy for addressing age-related diseases. By increasing our understanding of how energy production affects aging, this study opens the door to future treatments aimed at promoting healthier aging across a wider population.

Future Perspectives and Conclusion

This study offers promising new insights but also demonstrates the complexity of cellular aging. The WRN gene plays a much broader role than DNA repair alone. It appears to regulate networks of genes linked to metabolism and genome organization. While boosting NAD+ can reduce some signs of cellular damage, it cannot fully compensate for the loss of WRN function.

Looking ahead, further research will be crucial to understanding how NAD+ operates in different parts of the cell and how it might work in combination with other treatments. For individuals with Werner syndrome, and potentially for the wider aging population, these findings bring us closer to future therapies aimed at improving health and longevity. 

Click here to read the full research paper in Aging.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

New Insights Into the Mechanisms of Sarcopenia

In this new study, researchers aimed to further elucidate the mechanisms of sarcopenia by examining the influence of denervation in young and middle-aged mice.

New Insights Into the Mechanisms of Sarcopenia

Listen to an audio version of this article

The Trending With Impact series highlights Aging publications (listed as “Aging (Albany NY)” by Medline/PubMed and “Aging-US” by Web of Science) that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

A hallmark characteristic of aging is the progressive loss of skeletal muscle mass, known as sarcopenia. A process called motor neuron denervation (Den)—when nerve signals to muscles are blocked or reduced—leads to muscle atrophy, fatigue and eventually muscle loss. Determining how and when Den events influence older muscles is crucially important for developing interventions to stop or reverse age-related muscle wasting.

“Further, aged muscle exhibits reduced plasticity to both enhanced and suppressed contractile activity. It remains unclear when the onset of this blunted response occurs, and how middle-aged muscle adapts to denervation.”

Dysfunctional mitochondria in muscle tissue are known to increase with age. Lysosomes are responsible for the recycling of damaged mitochondria. However, as muscles age, lysosomal function in muscle tissue also declines.

In a new study, researchers Matthew Triolo, Debasmita Bhattacharya and David A. Hood from York University in Toronto, Canada, aimed to characterize the time-dependent changes in denervated skeletal muscle from middle-aged mice. The team focussed on how mitochondrial turnover is impacted. On November 4, 2022, their research paper was published in Aging’s Volume 14, Issue 22, entitled, “Denervation induces mitochondrial decline and exacerbates lysosome dysfunction in middle-aged mice.”

The Study

“The purpose of this study was to compare mitochondrial turnover pathways in young (Y, ~5months) and middle-aged (MA, ~15months) mice, and determine the influence of Den.”

Male mt-Keima mice aged 4-6 months (young) and 14-16 months (middle-aged) were included in this study. The researchers performed surgical procedures to induce Den in the hindlimb muscles of the study mice. After one, three, or seven days of Den, tissue was excised and imaged using confocal microscopy. The researchers collected whole-muscle protein extracts and conducted Western blotting. Statistical analysis was performed using the data they collected.

The middle-aged muscles were compared to muscles from control and young mice. The researchers found that muscle mass, mitochondrial content and PGC-1α protein levels were not different between the young and middle-aged mice. However, indications of enhanced mitochondrial fission and mitophagy and a greater abundance of lysosome proteins were evident in the middle-aged muscle. Their data suggest that increases in fission drive an acceleration of mitophagy in middle-aged murine muscle in order to preserve mitochondrial quality. 

“Den exacerbates the aging phenotype by reducing biogenesis in the absence of a change in mitophagy, perhaps limited by lysosomal capacity, leading to an accumulation of dysfunctional mitochondria with an age-related loss of neuromuscular innervation.”

Conclusion

“In our present study, the inability to upregulate mitophagy flux with denervation is driven by a combination of 1) failure to increase mitophagic proteins and 2) the appearance of dysfunctional lysosomes.”

This latest study may shed light on how muscles age and reveal the importance of mitophagy and lysosomal function in maintaining healthy muscles among middle-aged mice. The study also highlights that denervation induces mitochondrial decline and exacerbates lysosome dysfunction in muscles, thereby worsening age-related muscular atrophy. Further studies are needed to gain a deeper understanding of the mechanisms behind these changes and how they can be prevented or reversed.

“Thus, therapies to combat muscle wasting with age-related physiologic denervation must be designed accordingly. Our results imply targeting both mitochondrial biogenesis and maintenance of lysosome capacity will serve to restore mitochondrial homeostasis and likely metabolic capacity of skeletal muscle.”

Click here to read the full research paper published by Aging.

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available at no cost to readers on Aging-us.com. Open-access journals have the power to benefit humanity from the inside out by rapidly disseminating information that may be freely shared with researchers, colleagues, family, and friends around the world.

For media inquiries, please contact [email protected].

Trending With Impact: Circulating Mitochondria and Inflamm-Aging

Authors from the National Institute on Aging wrote a trending editorial paper on mitochondria extracellular vesicles and aging.

Figure 1. Mitochondrial DNA in extracellular vesicles and association with human aging.
Figure 1. Mitochondrial DNA in extracellular vesicles and association with human aging.
Listen to an audio version of this article

The Trending With Impact series highlights Aging publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Some structures inside cells play elusive, yet important roles in human aging. Researchers believe structures classified as extracellular vesicles (EVs), released outside of cell walls, may also play key components in the aging process—specifically related to chronic inflammation.

“EVs are lipid-bound nano-sized vesicles that are secreted outside of cells into the circulation (Figure 1A).”

Two researchers from the National Institutes of Health‘s National Institute on Aging wrote a trending editorial paper, published by Aging in 2021, and entitled, “Mitochondria as extracellular vesicle cargo in aging.” 

Inflammation and Aging

The term “inflamm-aging” has been coined to describe the common state of chronic low-grade inflammation associated with aging. Researchers believe that inflammation contributes to many age-related diseases, including cardiovascular disease, diabetes, cancer, and even dementia.

“In fact, inflammation-related diseases account for more than 50% of worldwide deaths, stressing the importance of inflammation in driving age-related disease and mortality [1,2].”

In the elderly, cellular damage and stress (among other causes) may contribute to chronic inflammation, which can initiate a release of mitochondrial damage-associated molecular patterns. This process can initiate cells to release mitochondrial DNA (mtDNA) into the space outside of the cell as circulating cell-free mitochondria DNA (ccf-mtDNA).

“Due to the similarities between mtDNA and bacterial DNA, this release can in turn elicit a sterile inflammatory response through activation of the innate immune system.”

Circulating Cell-Free Mitochondria DNA

Authors of this editorial believe that ccf-mtDNA may contribute to systemic chronic inflammation. In a previous study, researchers found, in general, that higher plasma/serum levels of ccf-mtDNA were reported in patients with inflammatory-related diseases and after acute injury or infection. However, ccf-mtDNA’s role in aging is complex, as one study showed that ccf-mtDNA levels initially decline into middle-age, and then gradually increase after age 50. 

The molecular details of how ccf-mtDNA exists within blood circulation has yet to be elucidated. Questions still linger surrounding whether or not components in the blood bind to ccf-mtDNA. If components do bind to ccf-mtDNA, are they capable of protecting ccf-mtDNA from destruction in circulation?

Extracellular Vesicles and mtDNA

“Given these gaps in the field, we recently explored whether plasma mtDNA can be encapsulated in extracellular vesicles (EVs) [5].”

The researchers evaluated multiple studies to find that mtDNA can be encapsulated in EVs isolated from plasma—both in cells that have been grown in vitro and in plasma EVs from patients with breast cancer. The next question the researchers addressed was: How do levels of mtDNA in plasma EVs fair in normal conditions and with age?

“To address this need, we isolated plasma EVs and analyzed mtDNA levels with human age. Individuals in this aging cohort had donated plasma at two different time points approximately 5 years apart, which enabled us to examine both crosssectional and longitudinal changes.”

Conclusion

“In both our cross-sectional and longitudinal analyses, EV mtDNA levels decreased with advancing age [5] (Figure 1B).”

The researchers concluded by reporting EV mtDNA levels decreased over a span of five years in the longitudinal cohort. Mitochondrial components, including mtDNA, may be important EV cargo. They emphasized that further research is needed and that it is important for researchers to consider age when using EVs as diagnostic or prognostic markers of disease. 

Click here to read the full editorial paper, published by Aging.

WATCH: MORE AGING VIDEOS ON LABTUBE

Aging is an open-access journal that publishes research papers monthly in all fields of aging research and other topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

2021 Ride for Roswell

For media inquiries, please contact [email protected].

  • Follow Us